← Leaderboards
Daniel Lewis Kraft
Stanford University
$1,615,279
Attributed
$1,615,279
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $516.4K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$1,615,279 · 2
By mechanism
R44$997,924 · 1
K08$617,355 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Robert S Negrin$29,816,136
- Mark M Davis$39,722,191
- Maximilian Diehn$12,346,945
- Edgar G. Engleman$35,389,843
- Ronald Wayne Davis$104,341,139
Others in their field
Top investigators on “Bone Marrow Transplantation”
- Charles A Coltman · Southwest Oncology Group$143,196,322
- Mary M Horowitz · Medical College Of Wisconsin$136,789,389
- Richard L Schilsky · University Of Chicago$50,742,272
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$48,601,153
- Kenneth C Anderson · Dana-Farber Cancer Inst$34,098,561
- Bruce R. Blazar · University Of Minnesota$32,866,133
Research focus
Bone Marrow TransplantationStem CellsDesignFutureAutologousAffectPhysiciansBone MarrowTechnologyFellowshipAntigen TargetingEvolutionAllogenicFluorochromeDisease ProgressionAdvisory CommitteesEngineeringBlast CellBioluminescenceConditioningAntigensDetectionCancer PatientBiological Models
Grant awards (7)
ADULT STEM CELL MINIMALLY INVASIVE BONE MARROW HARVESTER$481,524
R44 · FY2012 · GM · contact PI
ADULT STEM CELL MINIMALLY INVASIVE BONE MARROW HARVESTER$516,400
R44 · FY2011 · GM · contact PI
Stem Cell-Derived Immunotherapy: Proof of Principle$123,471
K08 · FY2009 · HL · contact PI
Stem Cell-Derived Immunotherapy: Proof of Principle$123,471
K08 · FY2008 · HL · contact PI
Stem Cell-Derived Immunotherapy: Proof of Principle$123,471
K08 · FY2007 · HL · contact PI
Stem Cell-Derived Immunotherapy: Proof of Principle$123,471
K08 · FY2006 · HL · contact PI
Stem Cell-Derived Immunotherapy: Proof of Principle$123,471
K08 · FY2005 · HL